FDA Backs Testing of Device Once Flagged for Covid Speculation

(Bloomberg) -- As far back as January, stock traders were latching onto Aethlon Medical Inc. and its experimental Hemopurifier device as a potential treatment for the novel coronavirus. After share...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.